All In MedTech

FDA Clearance Tracker · K221823

Cionic Neural Sleeve NS-100

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Jul 21, 2022 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Jul 21, 2022

Substantially Equivalent

Time to decision

28 days

Received Jun 23, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Special

Device class

Class II

The decision

FDA number
K221823
Device name
Cionic Neural Sleeve NS-100
Applicant
Cionic
Applicant location
San Francisco, CA
Received
Jun 23, 2022
Decided
Jul 21, 2022
Decision
Substantially Equivalent
Submission type
Special

Device type

Device class
Class II
Regulation
21 CFR 882.5810

Every decision under product code GZI

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code GZI. The earliest in FDA's data is K770725, decided Apr 26, 1977.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Cionic

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.